Aemetis (NASDAQ:AMTX) Shares Pass Below 200-Day Moving Average of $3.43

Aemetis, Inc. (NASDAQ:AMTX) shares crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $3.43 and traded as low as $2.44. Aemetis shares last traded at $2.45, with a volume of 339,125 shares.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on AMTX shares. StockNews.com raised Aemetis to a “sell” rating in a research report on Wednesday, July 31st. Truist Financial reissued a “hold” rating and set a $3.50 price objective (down previously from $4.00) on shares of Aemetis in a research report on Wednesday, July 31st. HC Wainwright restated a “buy” rating and set a $28.00 target price on shares of Aemetis in a report on Friday, August 2nd. UBS Group decreased their price target on shares of Aemetis from $8.25 to $7.75 and set a “buy” rating for the company in a research note on Monday, August 19th. Finally, Ascendiant Capital Markets dropped their price objective on shares of Aemetis from $20.00 to $19.00 and set a “buy” rating on the stock in a research note on Tuesday, September 3rd. One analyst has rated the stock with a sell rating, one has given a hold rating and four have given a buy rating to the company. According to data from MarketBeat, Aemetis currently has an average rating of “Moderate Buy” and a consensus target price of $12.95.

Aemetis Trading Up 4.8 %

The business’s fifty day moving average is $2.64 and its two-hundred day moving average is $3.42. The company has a market capitalization of $106.56 million, a PE ratio of -2.05 and a beta of 1.25.

Aemetis (NASDAQ:AMTX) last announced its quarterly earnings results on Thursday, August 1st. The specialty chemicals company reported ($0.66) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.41) by ($0.25). The firm had revenue of $66.56 million during the quarter, compared to analysts’ expectations of $75.37 million. During the same quarter in the prior year, the firm posted ($0.68) earnings per share. As a group, equities research analysts anticipate that Aemetis, Inc. will post -2.19 EPS for the current year.

Hedge Funds Weigh In On Aemetis

Several institutional investors have recently bought and sold shares of the stock. SG Americas Securities LLC purchased a new position in shares of Aemetis in the 1st quarter worth $60,000. State Board of Administration of Florida Retirement System bought a new position in shares of Aemetis in the 1st quarter valued at about $84,000. Bank of New York Mellon Corp bought a new stake in Aemetis during the second quarter worth approximately $306,000. Hutchinson Capital Management CA bought a new stake in Aemetis during the second quarter worth approximately $70,000. Finally, Susquehanna Fundamental Investments LLC raised its position in Aemetis by 287.4% during the second quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company’s stock valued at $379,000 after purchasing an additional 93,536 shares during the period. 27.02% of the stock is owned by hedge funds and other institutional investors.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.